Notice Number: NOT-DK-07-002

Key Dates
Release Date:   January 23, 2007

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov)

The National Institute of Diabetes and Digestive Diseases (NIDDK) announces the termination of the PA-06-176: Insulin Signalling and Receptor Cross-Talk (R21).

New or revised applications will NOT be accepted for the above reference PA after January 23, 2007.

The NIDDK is participating in the NIH Exploratory/Developmental Research Grant Program (Parent R21) which may found at http://grants.nih.gov/grants/guide/pa-files/PA-06-181.html.  Information about NIDDK’s R21 program can be found at  http://www2.niddk.nih.gov/Funding/Grants/ApplicantGuidelines/R21.htm . Applicants with research interest in areas important to the NIDDK mission, who are considering applying to the Parent R21 announcement, are encouraged to consult with NIDDK Program Staff before submitting an application.

Inquiry

For questions regarding research areas important to the mission of NIDDK please contact:

For Diabetes, Endocrinology, and Metabolic Diseases:

Catherine McKeon, Ph.D.
6707 Democracy Boulevard, Room 6103
Bethesda, MD 20892-5460
Telephone: (301) 594-8810
FAX: (301) 480-3503
E-mail: [email protected]

For Digestive Diseases, Obesity, and Nutrition:

Robert Karp, Ph.D.
6707 Democracy Boulevard, Room 671
Bethesda, MD 20892-5450
Telephone: (301)451-8875
FAX: (301) 480-8300
E-mail: [email protected]

For Kidney and Urologic Disorders:

Christian Ketchum, Ph.D.  
6707 Democracy Boulevard, Room 647
Bethesda, MD 20892-5458
Telephone: (301) 594-7717
FAX:  (301) 480-3510
E-mail: [email protected]